1.Genetic counselling in prenatal genetic testing.
Journal of Genetic Medicine 2007;4(1):6-14
No abstract available.
2.The recent trend of prenatal screening.
Journal of Genetic Medicine 2008;5(1):7-14
Twenty years have passed since a prenatal screening for Down syndrome and neural tube defect was applied to obstetric field. The Quad test (AFP, hCG, uE3, Inhibin-A) of the second trimester and the combination test (PAPP-A, hCG, NT) of the first trimester became popular now. The recent trend of prenatal screening is to combine these two screening tests together in order to increase a detection rate of Down syndrome. Three types of screening methods are introduced as follows; integrated test, sequential test and contingent test. In addition to combination of each test, an incorporation of characteristic ultrasound findings of Down syndrome is suggested for its risk calculation. The absence of fetal nasal bone would be a very useful marker especially in the first trimester screening test. According to a change of way calculating risk of Down syndrome, obstetrician's role will be more increased not by passive participation, but by active participation using ultrasound in risk calculation.
Adenine
;
Carbamates
;
Deoxycytidine
;
Down Syndrome
;
Drug Combinations
;
Female
;
Humans
;
Mass Screening
;
Nasal Bone
;
Neural Tube Defects
;
Organophosphonates
;
Pregnancy
;
Pregnancy Trimester, First
;
Pregnancy Trimester, Second
;
Prenatal Diagnosis
;
Quinolones
;
Thiazoles
;
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
3.Rapid detection of aneuploidy using FISH in uncultured amniocytes for prenatal diagnosis : 8-year experience.
Doyeong HWANG ; Dong Suk LEE ; Jin CHOE ; Hyeh Sook CHOI ; Jeongyong MIN ; Soomin LEE ; Ki Chul KIM
Journal of Genetic Medicine 2007;4(2):190-195
PURPOSE: FISH is suggested as a useful tool for rapid detection of specific aneuploidy in uncultured amniocytes abnormality in interphase nucleus. In this study, we are going to share our experience using FISH in prenatal diagnosis and suggest the criteria for the diagnosis of aneuploidy by analyzing the results of FISH test. METHODS: From January, 1999 to May, 2006, 8,613 tests in amniotic fluids obtained from 7,893 pregnant women were performed by using FISH for prenatal diagnosis of trisomy 21, trisomy 18 and trisomy 13. The indications of chromosome study were a screen positive for Down syndrome or Edwards syndrome in maternal serum marker screening test and an advanced maternal age (> or =35 years old). RESULTS: We have the 8,502 informative results from 8,613 tests (98.7%) which is submitted our criteria and the sensitivity is 98.2%. CONCLUSION: FISH on uncultured amniocytes is a rapid, clinically useful tool for prenatal diagnosis, with informative specimens being highly accurate. But the limitation of FISH is both expensive and labor-intensive.
Amniotic Fluid
;
Aneuploidy*
;
Biomarkers
;
Diagnosis
;
Down Syndrome
;
Female
;
Humans
;
Interphase
;
Mass Screening
;
Maternal Age
;
Pregnant Women
;
Prenatal Diagnosis*
;
Trisomy
4.Development of medical genetics training program and certification process for medical geneticist as a specialist in Korea.
Han Wook YOO ; Doyeong HWANG ; Hyun Mee RYU ; Hong Jin LEE ; Hyon J KIM
Journal of Genetic Medicine 2007;4(2):142-159
PURPOSE: This study was undertaken to provide prerequisites for accreditation of medical genetics training program and certification process for medical genetics professionals as clinical specialist and set up guidelines on curriculum of medical genetics training program in Korea. METHODS: Six ad hoc committees for clinical geneticist, clinical cytogeneticist, clinical molecular geneticist, clinical biochemical geneticist, medical genetics technologists and genetic counselors were organized for reviewing current status in Korea as well as foreign countries. Each committee is composed of 6-8 members. They summarized their opinions according to the structured questionnaire inquiring the ways of accrediting training program, qualification of program director, trainee requirements, contents of curriculum, duration of training program, certification process, estimation of numbers of each specialist needed in next 5 years in Korea. RESULTS: Both prerequisites for the accreditation of medical geneticist training institutions and qualification of program director are suggested. Candidacy of trainees requires MD with board of medical specialty, or PhD degree with professional experiences in related field except clinical genetics program which only accepts MD with board of medical specialty, and Non-MD genetic counselor and medical technologists with degrees of BS or MS. General duration of fellowship will be 2-3 years depending on the categories they are enrolled into. Contents of curriculum for each speciality training are described. For the certification of each category, the candidacy should submit a log book detailing the cases they experienced during the fellowship, prove that they successfully completed course work and clinical experiences in the accredited program, and pass the written examination. CONCLUSION: As medical genetics becomes more important in daily routine clinical practice, the accreditation of medical genetics training program and certification of personnel are urgently needed. In this regard, the study will be providing guidelines and prerequisites for accreditation of medical genetics training program and certification process for medical genetics professionals as clinical specialist.
Accreditation
;
Certification*
;
Counseling
;
Curriculum
;
Education*
;
Fellowships and Scholarships
;
Genetics
;
Genetics, Medical*
;
Humans
;
Korea*
;
Medical Laboratory Personnel
;
Specialization*
;
Surveys and Questionnaires
5.The Recurrent Pregnancy Loss Associated with a Female Carrier of a Structural Chromosome Rearrangement.
Soomin LEE ; Sanghee GO ; Sookyung JO ; Sohyun PARK ; Soojin MOON ; Dongsuk LEE ; Ki Chul KIM ; Doyeong HWANG
Journal of Genetic Medicine 2010;7(2):156-159
Inversion, one of the balanced rearrangements, usually does not lead to phenotypic abnormalities; all genetic information exists in the proper amount, merely in a different order or in an abnormal location. However, offspring of an inversion carrier is at risk of chromosomal imbalance because an inversion loop can be formed during crossing-over of the paternal and the maternal chromosomes in meiosis. We report a 38-year-old woman with inversion and balanced translocation and her fetus with unusual rearrangement causing chromosomal imbalance. We performed conventional cytogenetic analysis, MLPA, and subtelomeric FISH in the cells of the embryo. The results showed that the distal portion of chromosome 13q was added to the terminal portion of chromosome 9p during crossing-over. Therefore, the final karyotype of the fetus was 46,XY,rec(9)t(9;13)(p22;q32)inv(9)(p12q13)mat, confirmed using molecular-cytogenetic analyzing tools.
Adult
;
Cytogenetic Analysis
;
Embryonic Structures
;
Female
;
Fetus
;
Humans
;
Karyotype
;
Meiosis
;
Pregnancy
6.Unbalanced translocation der(8)t(8:13)(p23.3;q32.1)dn identified by array CGH and subtelomeric FISH in a patient with mental retardation.
Soomin LEE ; Dongsuk LEE ; Hyunah JEONG ; Kichul KIM ; Doyeong HWANG
Journal of Genetic Medicine 2008;5(1):65-68
Molecular cytogenetics allows the identification of unknown chromosome rearrangements, which is clinically useful in patients with mental retardation and/or development delay. We report on a 31-year- old woman with severe mental retardation, behavior development delay, and verbal performance delay. Conventional cytogenetic analysis showed a 46,XX,add(8)(p23.3) karyotype. To determine the origin of this unbalanced translocation, we performed array CGH and subtelomeric FISH. The results showed that the distal region of chromosome 8p was added to the terminal of chromosome 13q. This was confirmed the final result of 46,XX,der(8)t(8:13)(p23.3;q32.1)dn.
Cytogenetic Analysis
;
Cytogenetics
;
Female
;
Humans
;
Intellectual Disability
;
Karyotype
7.Expression of the genes for peroxisome proliferator-activated receptor-γ, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome.
Joong Yeup LEE ; Jin Cheol TAE ; Chung Hyon KIM ; Doyeong HWANG ; Ki Chul KIM ; Chang Suk SUH ; Seok Hyun KIM
Clinical and Experimental Reproductive Medicine 2017;44(3):146-151
OBJECTIVE: To identify differences in the expression of the genes for peroxisome proliferator-activated receptor (PPAR)-γ, cyclooxygenase (COX)-2, and the proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α in granulosa cells (GCs) from polycystic ovary syndrome (PCOS) patients and controls undergoing controlled ovarian stimulation. METHODS: Nine patients with PCOS and six controls were enrolled in this study. On the day of oocyte retrieval, GCs were collected from pooled follicular fluid. Total mRNA was extracted from GCs. Reverse transcription was performed and gene expression levels were quantified by realtime quantitative polymerase chain reaction. RESULTS: There were no significant differences in age, body mass index, and total gonadotropin dose, except for the ratio of luteinizing hormone to follicle-stimulating hormone between the PCOS and control groups. PPAR-γ and COX-2 mRNA was significantly downregulated in the GCs of PCOS women compared with controls (p=0.034 and p=0.018, respectively), but the expression of IL-6 and TNF-α mRNA did not show significant differences. No significant correlation was detected between the expression of these mRNA sequences and clinical characteristics, including the number of retrieved oocytes, oocyte maturity, cleavage, or the good embryo rate. Positive correlations were found among the PPAR-γ, COX-2, IL-6, and TNF-α mRNA levels. CONCLUSION: Our data may provide novel clues regarding ovarian GC dysfunction in PCOS, and indirectly provide evidence that the effect of PPAR-γ agonists in PCOS might result from alterations in the ovarian follicular environment. Further studies with a larger sample size are required to confirm these proposals.
Body Mass Index
;
Cyclooxygenase 2*
;
Cytokines*
;
Embryonic Structures
;
Female
;
Follicle Stimulating Hormone
;
Follicular Fluid
;
Gene Expression
;
Gonadotropins
;
Granulosa Cells*
;
Humans
;
Interleukin-6
;
Interleukins
;
Luteinizing Hormone
;
Oocyte Retrieval
;
Oocytes
;
Ovulation Induction
;
Peroxisomes*
;
Polycystic Ovary Syndrome*
;
Polymerase Chain Reaction
;
PPAR gamma
;
Prostaglandin-Endoperoxide Synthases
;
Reverse Transcription
;
RNA, Messenger
;
Sample Size
;
Tumor Necrosis Factor-alpha
8.Clinical application of chromosomal microarray for pathogenic genomic imbalance in fetuses with increased nuchal translucency but normal karyotype
Dongsook LEE ; Sanghee GO ; Sohyun NA ; Surim PARK ; Jinyoung MA ; Doyeong HWANG
Journal of Genetic Medicine 2020;17(1):21-26
Purpose:
To evaluate the additive value of prenatal chromosomal microarray analysis (CMA) in assessing increased nuchal translucency (NT) (≥3.5 mm) with normal karyotype and the possibility of detecting clinically significant genomic imbalance, based on specific indications.
Materials and Methods:
Invasive samples from 494 pregnancies with NT ≥3.5 mm, obtained from the Research Center of Fertility & Genetics of Hamchoon Women’s Clinic between January 2019 and February 2020, were included in this study and CMA was performed in addition to a standard karyotype.
Results:
In total, 494 cases were subjected to both karyotype and CMA analyses. Among these, 199 cases of aneuploidy were excluded. CMA was performed on the remaining 295 cases (59.7%), which showed normal (231/295, 78.3%) or non-significant copy number variation (CNV), such as benign CNV or variants of uncertain clinical significance likely benign (53/295, 18.0%). Clinically significant CNVs were detected in 11 cases (11/295, 3.7%).
Conclusion
Prenatal CMA resulted in a 3% to 4% higher CNV diagnosis rate in fetuses exhibiting increased NT (≥3.5 mm) without other ultrasound detected anomalies and normal karyotype. Therefore, we suggest using high resolution, non- targeting CMA to provide valuable additional information for prenatal diagnosis. Further, we recommend that a genetics specialist should be consulted to interpret the information appropriately and provide counseling and follow-up services after prenatal CMA.
9.Detection of Adeno-associated Virus from Semen Suffering with Male Factor Infertility and Having Their Conception Partners with Recurrent Miscarriages.
Chung Hyon KIM ; Jung Heon KIM ; Hyun Jung KIM ; Kun Woo KIM ; Joong Yeup LEE ; Soon Ha YANG ; Jin CHOE ; Doyeong HWANG ; Ki Chul KIM ; Eung Soo HWANG
Journal of Bacteriology and Virology 2012;42(4):339-345
Adeno-associated virus (AAV) and human papillomavirus (HPV) DNAs were found in abnormal quality semen, early abortus and female genital tissues. It was suggested that they might cause male infertility and miscarriages. This study was performed to determine the detection rate of these viruses in the semen and to assess the relationship between the presence of virus and male factor infertility and recurrent miscarriages. Sixty-three of 99 recruited male were included in this study according to the completeness of follow-up and the sample availability. Fourteen male with normal reproductive capacity were allocated to control group, 15 male with abnormal results in semen analysis were grouped as male factor infertility (MF) group, and 34 male whose spouses have had history of repeated spontaneous abortions were designated as repeated miscarriage (RM) group. AAV and HPV were detected in semen by polymerase chain reaction. The detection rate of AAV in the MF infertility group and RM group was 60.0% and 50.0%, respectively, while 14.3% in the control group (p < 0.05). However, the differences in the detection rate of HPV were not statistically significant among groups. These results suggest that AAV could be related to repeated miscarriages and male infertility.
Abortion, Habitual
;
Abortion, Spontaneous
;
Dependovirus
;
DNA
;
Female
;
Fertilization
;
Follow-Up Studies
;
Humans
;
Infertility
;
Infertility, Male
;
Male
;
Polymerase Chain Reaction
;
Pregnancy
;
Semen
;
Semen Analysis
;
Spouses
;
Stress, Psychological
;
Viruses
10.Outcomes of preimplantation genetic diagnosis using either zona drilling with acidified Tyrode's solution or partial zona dissection.
Hyun Jung KIM ; Chung Hyon KIM ; Soo Min LEE ; Seung Ah CHOE ; Joong Yeup LEE ; Byung Chul JEE ; Doyeong HWANG ; Ki Chul KIM
Clinical and Experimental Reproductive Medicine 2012;39(3):118-124
OBJECTIVE: To review the outcomes of preimplantation genetic diagnosis (PGD) using zona drilling with acid Tyrode's solution (chemical zona pellucida drilling, chemical ZD) and those of partial zona dissection (PZD). METHODS: Clinical outcomes of seventy-one couples undergoing 85 PGD cycles from January 2005 to December 2010 were included. Blastocyst formation and the hatching rate, clinical pregnancy rate, ongoing pregnancy rate, implantation rate, and fetal gender ratio of the PZD and chemical ZD groups were compared. RESULTS: Application of PZD resulted in a significantly higher rate of clinical pregnancy (40.7% vs. 15.4%, p=0.022), ongoing pregnancy (35.6% vs. 11.5%, p=0.023), and implantation (18.1% vs. 5.7%, p=0.007) compared with chemical ZD. Among non-transferred embryos, the rate of blastocyst formation on day 5 (49.1% vs. 39.5%, p=0.016) and hatching on day 6 (47.2% vs. 26.5%, p<0.001) were also significantly higher in the PZD group. CONCLUSION: The mechanical zona dissection method showed better outcomes than chemical ZD in terms of the blastocyst development and pregnancy rate. In this study, the fact that chemical ZD was conducted in different period from mechanical method should be considered in interpreting the result.
Blastocyst
;
Embryonic Structures
;
Family Characteristics
;
Herpes Zoster
;
Isotonic Solutions
;
Mandrillus
;
Pregnancy
;
Pregnancy Rate
;
Preimplantation Diagnosis
;
Prostaglandins D
;
Zona Pellucida